bio sketch column
Jo Redmond is a Scientific Leader in the Chemical Biology group at GSK, where she leads the Chemogenomic screening platform and its application to support target identification for drug discovery programs. Jo joined GSK as a Medicinal Chemist in 2008 and has led Medicinal Chemistry efforts for kinase, integrin and GPCR-based drug discovery programs. These projects have included small molecule modulators and PROTACs, spanning both hit-to-lead and lead optimisation activities. From 2017 to 2019 she worked at the Francis Crick Institute in the GSK/Crick LinkLabs as a Medicinal Chemistry Leader and developed an approach utilising orally bioavailable small molecule “bumped” kinase inhibitors in conjunction with targeted genetic mutation to explore full organism kinase biology. Prior to joining GSK, Jo completed a PhD in stereoselective synthesis at Imperial College London and a Masters in Chemistry at the University of Oxford.